Vanda Pharmaceuticals (VNDA) Current Assets (2016 - 2025)
Historic Current Assets for Vanda Pharmaceuticals (VNDA) over the last 17 years, with Q3 2025 value amounting to $367.5 million.
- Vanda Pharmaceuticals' Current Assets fell 1500.76% to $367.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $367.5 million, marking a year-over-year decrease of 1500.76%. This contributed to the annual value of $438.9 million for FY2024, which is 137.29% up from last year.
- Per Vanda Pharmaceuticals' latest filing, its Current Assets stood at $367.5 million for Q3 2025, which was down 1500.76% from $394.9 million recorded in Q2 2025.
- Over the past 5 years, Vanda Pharmaceuticals' Current Assets peaked at $536.6 million during Q3 2023, and registered a low of $367.5 million during Q3 2025.
- Moreover, its 5-year median value for Current Assets was $446.7 million (2021), whereas its average is $462.1 million.
- Its Current Assets has fluctuated over the past 5 years, first surged by 1855.4% in 2021, then tumbled by 1941.68% in 2024.
- Over the past 5 years, Vanda Pharmaceuticals' Current Assets (Quarter) stood at $478.3 million in 2021, then rose by 8.57% to $519.3 million in 2022, then decreased by 16.63% to $432.9 million in 2023, then increased by 1.37% to $438.9 million in 2024, then dropped by 16.27% to $367.5 million in 2025.
- Its last three reported values are $367.5 million in Q3 2025, $394.9 million for Q2 2025, and $407.9 million during Q1 2025.